Dishman Carbogen Amcis Profit & Loss Annual

Trade
BSE: 540701 | NSE: DCAL | ISIN: INE385W01011 | Sector: Biotechnology & Drugs
231.50 +2.95 (1.29%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 2,615.772,412.922,140.691,912.03
Total Revenue 2,615.772,412.922,140.691,912.03
Costof Revenue Total 597.19615.71520.77524.66
Gross Profit 2,018.581,797.211,619.921,387.37
Selling/ General/ Admin Expenses Total 1,208.161,317.891,254.341,090.79
Depreciation/ Amortization 310.86280.72307.59307.66
Unusual Expense( Income) 15.32122.4233.0722.28
Other Operating Expenses Total 514.7418.859.696.04
Total Operating Expense 2,646.272,355.592,125.461,951.71
Operating Income -30.5057.3315.23-39.68
Interest Inc( Exp) Net- Non- Op Total -1,199.70-1,104.50-281.20-311.10
Other Net 28.212.1010.575.58
Net Income Before Taxes -122.26-54.59-4.25-65.03
Provisionfor Income Taxes 31.19-24.79-22.26100.10
Net Income After Taxes -153.45-29.8018.01-165.13
Minority Interest 0.00-0.000.00
Net Income Before Extra Items -153.45-29.8018.01-165.13
Net Income -153.45-29.8018.01-165.13
Income Availableto Com Excl Extra Ord -153.45-29.8018.01-165.13
Income Availableto Com Incl Extra Ord -153.45-29.8018.01-165.13
Diluted Net Income -153.45-29.8018.01-165.13
Diluted Weighted Average Shares 15.6715.6815.6815.68
Diluted EPS Excluding Extra Ord Items -9.79-1.901.15-10.53
Diluted Normalized EPS -9.156.248.24-3.97
Gain( Loss)on Saleof Assets --35.70-19.301.80
Interest Exp( Inc) Net- Operating Total ---2.80
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts